Exelon (NASDAQ:EXC - Get Free Report) had its price target upped by equities research analysts at Scotiabank from $42.00 to $44.00 in a research report issued on Thursday,Benzinga reports. The firm presently has a "sector perform" rating on the stock. Scotiabank's price objective would suggest a potential upside of 2.68% from the company's current price.
A number of other research analysts also recently commented on the company. Morgan Stanley reduced their price target on Exelon from $46.00 to $44.00 and set an "equal weight" rating for the company in a report on Friday, November 22nd. Evercore ISI raised Exelon from an "in-line" rating to an "outperform" rating and increased their target price for the stock from $43.00 to $44.00 in a report on Tuesday, January 21st. Barclays reduced their target price on Exelon from $44.00 to $42.00 and set an "overweight" rating on the stock in a report on Wednesday, January 22nd. Finally, Guggenheim raised Exelon from a "neutral" rating to a "buy" rating in a report on Thursday, January 23rd. Five investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to MarketBeat.com, Exelon has a consensus rating of "Moderate Buy" and a consensus target price of $43.38.
Read Our Latest Stock Analysis on EXC
Exelon Stock Down 0.3 %
EXC traded down $0.12 on Thursday, reaching $42.85. The company's stock had a trading volume of 8,592,975 shares, compared to its average volume of 6,724,702. The stock has a market cap of $43.06 billion, a price-to-earnings ratio of 17.63, a price-to-earnings-growth ratio of 2.74 and a beta of 0.56. Exelon has a 1 year low of $34.01 and a 1 year high of $43.45. The company has a debt-to-equity ratio of 1.66, a current ratio of 1.09 and a quick ratio of 0.97. The business's 50 day moving average is $38.72 and its 200 day moving average is $38.87.
Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, beating analysts' consensus estimates of $0.59 by $0.05. Exelon had a return on equity of 9.47% and a net margin of 10.60%. During the same period in the prior year, the company earned $0.60 earnings per share. As a group, research analysts forecast that Exelon will post 2.46 EPS for the current fiscal year.
Insider Buying and Selling
In related news, EVP Colette D. Honorable sold 1,463 shares of the firm's stock in a transaction that occurred on Monday, February 3rd. The stock was sold at an average price of $40.57, for a total value of $59,353.91. Following the sale, the executive vice president now owns 2,271 shares of the company's stock, valued at approximately $92,134.47. This trade represents a 39.18 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.10% of the company's stock.
Institutional Trading of Exelon
Hedge funds have recently added to or reduced their stakes in the business. Millstone Evans Group LLC bought a new stake in Exelon during the 4th quarter valued at $28,000. Stephens Consulting LLC raised its stake in Exelon by 78.1% during the 4th quarter. Stephens Consulting LLC now owns 782 shares of the company's stock valued at $29,000 after acquiring an additional 343 shares in the last quarter. Ashton Thomas Securities LLC bought a new stake in Exelon during the 3rd quarter valued at $32,000. Brown Lisle Cummings Inc. bought a new stake in Exelon during the 4th quarter valued at $30,000. Finally, Crews Bank & Trust bought a new stake in Exelon during the 4th quarter valued at $34,000. Institutional investors own 80.92% of the company's stock.
Exelon Company Profile
(
Get Free Report)
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
Read More
Before you consider Exelon, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.
While Exelon currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
